Related Experiment Video
Updated: Jan 7, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Targeting Molecular Dysregulation in Ulcerative Colitis: A Paired Cellular Perspective on CD4+, CD8+, and IL-6
Roxana Elena Mirica1,2,3, Andrei Coman4, Monica State5
1Department of Social Insurance Medicine, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Abstract:
Histological healing is increasingly recognized as a sensitive marker of disease remission in ulcerative colitis (UC). However, the dynamics of mucosal T lymphocytes and proinflammatory cytokines during healing remain incompletely understood. In this paired, within-subject observational study (retrospective analysis of paired biopsies), colonic biopsy sets from 20 adult UC patients were analyzed during active inflammation and at a subsequent time point of histologic healing. Immunohistochemistry was performed for CD3, CD4, CD8, and IL-6. Lymphocyte densities were quantified in intraepithelial and lamina propria compartments, while IL-6 expression was scored semi-quantitatively. Histological activity was assessed using the Geboes score. Intraepithelial CD4+ T cells significantly decreased during histologic healing (mean 6.8 → 3.75 cells/100 epithelial cells, p < 0.05), whereas lamina propria CD4+ cells remained variably persistent, suggesting ongoing immune regulation. Intraepithelial CD8+ cells increased during remission, indicating a potential reparative or surveillance role. IL-6 expression markedly declined in epithelial and stromal compartments during healing, reflecting resolution of mucosal inflammation. Correlation analyses revealed enhanced coordination between CD4+ and CD8+ cells in the healing phase, consistent with immune homeostasis. Histologic healing in UC involves compartment-specific shifts in T lymphocyte populations and a marked reduction in IL-6 expression, reflecting coordinated immune regulation beyond clinical remission. These findings highlight the potential of combined cellular and cytokine biomarkers to monitor mucosal healing and guide immunomodulatory therapies.
Insights
Histologic healing in ulcerative colitis (UC) involves changes in T cells and reduced IL-6. This suggests coordinated immune regulation beyond clinical remission, potentially guiding future therapies.
Area of Science:
- Gastroenterology
- Immunology
- Cellular Biology
Background:
- Histological healing is a key indicator of remission in ulcerative colitis (UC).
- The roles of mucosal T lymphocytes and cytokines during UC healing are not fully understood.
Purpose of the Study:
- To investigate the dynamics of T lymphocytes (CD4+, CD8+) and IL-6 during histologic healing in UC patients.
- To correlate these changes with disease activity and immune homeostasis.
Main Methods:
- Retrospective analysis of paired colonic biopsies from 20 adult UC patients during active inflammation and healing.
- Immunohistochemistry for CD3, CD4, CD8, and IL-6.
- Quantification of lymphocyte densities and semi-quantitative IL-6 scoring.
Main Results:
- Intraepithelial CD4+ T cells decreased, while intraepithelial CD8+ T cells increased during healing.
- Lamina propria CD4+ T cells showed variable persistence.
- IL-6 expression significantly decreased in epithelial and stromal compartments.
- Enhanced coordination between CD4+ and CD8+ cells was observed during healing.
Conclusions:
- Histologic healing in UC involves compartment-specific T cell shifts and reduced IL-6.
- These changes reflect coordinated immune regulation and resolution of inflammation.
- Cellular and cytokine biomarkers may help monitor healing and guide UC therapies.
More Related Videos
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025